Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Xavier G. L. V. Pouwels, Robert Wolff, Bram L. T. Ramaekers, Anoukh Van Giessen, Shona Lang, Steve Ryder, Gill Worthy, Steven Duffy, Nigel Armstrong, Jos Kleijnen, Manuela A. Joore

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)533-543
Number of pages11
JournalPharmacoeconomics
Volume36
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • CHARISMA TRIAL
  • CLOPIDOGREL
  • RATIONALE
  • ASPIRIN
  • DESIGN
  • RISK
  • 1ST

Cite this